![Interleukin-23 in Psoriasis: Integrating New Therapies in the Current Treatment Landscape - European Medical Journal Interleukin-23 in Psoriasis: Integrating New Therapies in the Current Treatment Landscape - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2018/02/Figure-1-Model-of-psoriasis-pathogenesis.2.jpg)
Interleukin-23 in Psoriasis: Integrating New Therapies in the Current Treatment Landscape - European Medical Journal
Interleukin-23-Blockade: neue Option für die Behandlung von PsA-Patienten in der Biologika-Erstlinien-Therapie
![Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease](https://f6publishing.blob.core.windows.net/5ef0c277-1856-4ebd-9bb8-bee6dd9811ba/WJG-24-4093-g001.jpg)
Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease
Psoriasis-Arthritis: IL-23-Inhibitoren beugen Progression zur Arthritis effektiver vor als TNFα-Hemmer
![Interleukin (IL)-12 and IL-23 structure and receptors. Notes: The IL-12... | Download Scientific Diagram Interleukin (IL)-12 and IL-23 structure and receptors. Notes: The IL-12... | Download Scientific Diagram](https://www.researchgate.net/profile/Matthieu-Bereau/publication/236615159/figure/fig1/AS:202503191830528@1425291931399/Interleukin-IL-12-and-IL-23-structure-and-receptors-Notes-The-IL-12-cytokine-is.png)
Interleukin (IL)-12 and IL-23 structure and receptors. Notes: The IL-12... | Download Scientific Diagram
![Frontiers | Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies Frontiers | Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies](https://www.frontiersin.org/files/Articles/621956/fimmu-12-621956-HTML-r1/image_m/fimmu-12-621956-g001.jpg)
Frontiers | Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
![Probing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET - ScienceDirect Probing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2451945621002191-fx1.jpg)
Probing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET - ScienceDirect
Interleukin-23-Blockade: neue Option für die Behandlung von PsA-Patienten in der Biologika-Erstlinien-Therapie
Chronische Psoriasisarthritis: Interleukin-23-Inhibitor reduziert die Krankheitsaktivität und ist gut verträglich
![IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases | Nature Medicine IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnm.3895/MediaObjects/41591_2015_Article_BFnm3895_Fig1_HTML.jpg)
IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases | Nature Medicine
![The TNF/IL‐23/IL‐17 axis—Head‐to‐head trials comparing different biologics in psoriasis treatment - ten Bergen - 2020 - Scandinavian Journal of Immunology - Wiley Online Library The TNF/IL‐23/IL‐17 axis—Head‐to‐head trials comparing different biologics in psoriasis treatment - ten Bergen - 2020 - Scandinavian Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/be68388f-9d5c-4ba8-b05f-8b9e18247bfa/sji12946-fig-0001-m.jpg)
The TNF/IL‐23/IL‐17 axis—Head‐to‐head trials comparing different biologics in psoriasis treatment - ten Bergen - 2020 - Scandinavian Journal of Immunology - Wiley Online Library
![IL-12 and IL-23 pathway inhibition in inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology IL-12 and IL-23 pathway inhibition in inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-023-00768-1/MediaObjects/41575_2023_768_Fig1_HTML.png)
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
![Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation? | Annals of the Rheumatic Diseases Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation? | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/78/8/1015/F2.large.jpg)
Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation? | Annals of the Rheumatic Diseases
![Inhibition of interleukin‐12 and/or interleukin‐23 for the treatment of psoriasis: What is the evidence for an effect on malignancy? - Ergen - 2018 - Experimental Dermatology - Wiley Online Library Inhibition of interleukin‐12 and/or interleukin‐23 for the treatment of psoriasis: What is the evidence for an effect on malignancy? - Ergen - 2018 - Experimental Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/00cafebc-b7d3-4e2e-b7a1-8e06b7b646ef/exd13676-fig-0001-m.jpg)
Inhibition of interleukin‐12 and/or interleukin‐23 for the treatment of psoriasis: What is the evidence for an effect on malignancy? - Ergen - 2018 - Experimental Dermatology - Wiley Online Library
![Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities | Dermatology and Therapy Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities | Dermatology and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs13555-021-00483-2/MediaObjects/13555_2021_483_Fig1_HTML.png)